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110Cyclosporine A normalizes mitochondrial coupling,
reactive oxygen species production, and
inﬂammation and partially restores skeletal muscle
maximal oxidative capacity in experimental aortic
cross-clamping
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Objective: By binding to cyclophilin D, cyclosporine A (CsA) inhibits mitochondrial permeability transition pore (mPTP)
opening and prevents mitochondrial dysfunction and ultimately cell death after ischemia-reperfusion (IR) injury in
cardiac muscle. This study tested whether CsA would decrease skeletal muscle oxidative stress and mitochondrial
dysfunctions after aortic cross-clamping related IR.
Methods: Forty-ﬁve Wistar rats were investigated. The sham group (n [ 8) had aortic exposure but no ischemia, the
IR group (n [ 10) had aortic cross-clamping for 3 hours followed by 2 hours of reperfusion, and the IRDCsA
group (n [ 9) had two intraperitoneal injections of 10 mg of CsA at 90 and 150 minutes of ischemia before
reperfusion. Mitochondrial coupling (acceptor control ratio) and mitochondrial respiratory chain complexes’
activities were measured. Reactive oxygen species (ROS) production, cyclophilin D expression, and muscle inﬂam-
mation were determined using dihydroethidium staining, Western blot, and immunohistochemistry, respectively. An
additional 18 sham rats were investigated to determine CsA blood levels and the effects of CsA on mitochondrial
respiration and calcium retention capacity, a marker of mPTP opening, both in myocardium and gastrocnemius
with and without CsA.
Results: Compared with sham, IR decreased mitochondrial coupling (1.38 6 0.06 vs 1.98 6 0.20; P[ .0092), increased
ROS production (3992 6 706 arbitrary units [AU] vs 1812 6 322 AU; P [ .033), was associated with mac-
rophage inﬁltration, and decreased maximal oxidative capacity (Vmax: 4.08 6 0.38 mmol O2/min/g vs 5.98 6 0.56 mmol
O2/min/g; P [ .015). Despite IR, CsA treatment totally restored mitochondrial coupling (1.93 6 0.12; P [ .023 vs
IR), normalized ROS (1569 6 348 AU; P[ .0098 vs IR), and decreased inﬂammation. The Vmax was slightly enhanced
(5.026 0.39 mmol O2/min/g; P[ .33 vs IR; P[ .35 vs sham). Compared with myocardium, gastrocnemius muscle was
characterized by a decreased cyclophilin D content (L50%) associated with an earlier opening of mPTP (calcium retention
capacity increased from 10.85 6 1.35 mM/mg dry weight [DW] to 12.11 6 2.77 mM/mg DW; P [ .65; and from
11.07 6 1.67 to 37.65 6 11.41 mM/mg DW; P [ .0098 in gastrocnemius and heart, respectively).
Conclusions: Cyclosporine A normalized ROS production, decreased inﬂammation, and restored mitochondrial coupling
during aortic cross-clamping. Incomplete Vmax protection might be due to low cyclophilin D expression in gastrocnemius,
preventing CsA from blocking mPTP opening. (J Vasc Surg 2013;57:1100-8.)
Clinical Relevance: Aortic cross-clamping increases reactive oxygen species production and impairs skeletal muscle
mitochondrial function. Even subtle muscle impairments may increase morbidity after abdominal aortic aneurysm repair,
supporting a need for muscle protection during vascular surgery. Albeit its protective effects might be related to muscle
content in cyclophilin D, this study demonstrates that cyclosporine A signiﬁcantly alleviates ischemia-reperfusion injury in
skeletal muscle. Because cyclosporine A can be used safely in humans, it might be an alternative or a synergistic therapeutic
approach to ischemic preconditioning in order to reduce mitochondrial dysfunction and reactive oxygen species
production in vascular patients undergoing aortic cross-clamping.Pôle Anesthésie Réanimation Chirurgicale, SAMU, Hôpitaux Univer-
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Fig 1. Experimental design. Sham animals (Sham; n ¼ 8)
underwent 5 hours of general anesthesia and were sham operated.
Ischemia-reperfusion animals (IR; n ¼ 10) underwent 3 hours of
ischemia induced by infrarenal aortic occlusion, followed by 2
hours of reperfusion. Cyclosporine-conditioned rats (IRþCsA;
n ¼ 9) also underwent 3 hours of ischemia, but complete reper-
fusion was preceded by two intraperitoneal cyclosporine A (CsA)
injections (10 mg/kg each) at 90 and 150 minutes of ischemia.
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 4 Pottecher et al 1101Open abdominal aortic aneurysm repair is a surgical
intervention commonly carried out in high-risk surgical
patients with advanced cardiovascular disease and compli-
cated outcomes.1 It requires aortic cross-clamping, which
induces skeletal muscle ischemia-reperfusion (IR) injury
that largely participates in perioperative and long-term
morbidity.2,3 Several mechanisms are involved in these alter-
ations, with key factors being increased reactive oxygen
species (ROS) production and impairedmitochondrial func-
tion. Particularly, themitochondrion is a central player in cell
survival. Indeed, mitochondria are the source of adenosine
triphosphate (ATP) storage, the main core of ROS genera-
tion4 and the mainstay of apoptosis regulation. At the
same time, the mitochondria are an early target of IR mech-
anisms. Indeed, ROS overproduction mediates IR-induced
mitochondrial dysfunction in skeletal muscles.5 Molecular
pathways then converge to a mitochondrial key target, the
mitochondrial permeability transition pore (mPTP), whose
opening causes both cell necrosis and apoptosis.6
In order to rescue skeletal muscle from infarction, local
and remote ischemic preconditioning equivalently pro-
tected muscles’ mitochondrial function against IR-
induced injury.7 Ischemic postconditioning, characterized
by repeated cycles of IR performed at the onset of reperfu-
sion, was also thought to be protective, but recent data
suggest it should be used with caution.8,9 Furthermore,
repetitive vascular clamping in atherosclerotic patients is
neither always feasible nor devoid of side effects,10 so there
is obviously a need for an alternative approach.
Pharmacologic conditioning is an option, and cyclo-
sporine A (CsA), a potent mPTP opening inhibitor, is
extremely powerful in protecting cardiomyocytes from
IR.11 Indeed, CsA binds to cyclophilin D and inhibits
mPTP opening, preventing mitochondrial dysfunction,
oxidative phosphorylation uncoupling, and ultimately cell
death.12 Cyclophilins are ubiquitous proteins, highly
conserved during evolution and identiﬁed in the genomes
of mammals, plants, insect, fungi, and bacteria.13 This
suggests that CsA effects should also be observed in a variety
of tissues, including human tissues. Other intracellular
mechanisms also could be at play. Thus, reduced ROS
production and reduced inﬂammation potentially might
participate in CsA biologic effects.14 Recently, Askar and
Bozkurt15 administered CsA before femoral occlusion and
observed decreased numbers of rolling, sticking, and trans-
migrating neutrophils in skeletal muscles submitted to 4
hours of ischemia and 24 hours of reperfusion. Importantly,
acute CsA administration should not be associated with
deleterious effects linked to persistent immunosuppression.
Thus, short-term CsA does not affect cutaneous or muscu-
lofascial wound healing in clinically relevant dose.16
The aim of this study was to test the hypothesis that, by
preventing mPTP opening, CsA would preserve mitochon-
drial coupling and mitochondrial complex activities, and
decrease ROS production and inﬂammation in gastrocne-
mius muscles submitted to IR. To obtain further insight
into the mechanisms involved in CsA effects, we also inves-
tigated whether cyclophilin D expression and mPTPopening might differ in myocardium and gastrocnemius
muscles.
METHODS
Procedures were conducted in accordance with U.S.
National Institutes of Health guidelines.
Animals. Experiments were performed on adult male
Wistar rats (Depré, Saint Doulchard, France) weighing
250 to 300 g. Animals were housed in a neutral tempera-
ture environment (22 6 2C) on a 12:12 hour photope-
riod and were provided food and water ad libitum.
Preoperative management. Rats were anesthetized
with a gas mixture containing 4% isoﬂurane and oxygen,
in a hermetic anesthetic induction cage (Aerrane; CSP,
Cournon, France). Spontaneous ventilation was allowed
through an oxygen-delivering mask, with different
concentrations of isoﬂurane depending on the surgical
phase (2% during painful stimuli and 1% during latent
periods). The rat’s temperature was maintained constant at
37C using blanket control (homeothermic blanket control
unit; MINERVE, Esternay, France) and monitored with
rectal probe.
Surgical procedure and experimental design.
Twenty-seven rats were divided into three groups (Fig 1).
The sham group (n ¼ 8) underwent 5 hours of isoﬂurane
anesthesia. A midline laparotomy was performed. The
posterior peritoneum was cut to expose the abdominal aorta
and the inferior vena cava. Infrarenal abdominal aorta was
dissected and liberated fromadjacent adhesions in all animals.
The IR group (n ¼ 10) underwent 3 hours of ischemia
induced by infrarenal aortic occlusion and collateral vessels
ligation, followed by 2 hours of reperfusion. The aorta was
temporally occluded using a DeBakey cross-action bulldog
clamp, and all arterial collaterals located between the renal
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using a thermal cautery (Geiger thermal cautery unit; Gei-
ger Medical Technologies, Council Bluffs, Iowa), as previ-
ously reported.7,8 After aortic clamping, the abdomen was
tightly closed to prevent dehydration. Ischemia was clini-
cally characterized by cyanosis and lack of arterial pulse
distal to the clamp. It was also ascertained by capillary
lactate measurements on the right foot before unclamping
(Lactate Pro device, LT1710; Arkray, KGK, Kyoto,
Japan).17 Lactates are end products of cellular anaerobic
energetic metabolism, a key biomarker of tissue hypoxia.
Using the same aortic clamping model, we observed
increased lactates and decreased skeletal muscle mitochon-
drial function, objectifying the degree of limb ischemia.7,8
The CsA-conditioned rats (IRþCsA; n¼ 9) also under-
went 3 hours of ischemia, but complete reperfusion was
preceded by two intraperitoneal 10 mg/kg CsA injections
(Sandimmun; Novartis-Pharma SAS, Rueil-Malmaison,
France) at 90 and 150 minutes of ischemia. Dose, adminis-
tration route, and timing were selected based on CsA phar-
macokinetic properties and protective doses in rats.18,19
Translated to IR protocols, an optimal CsA level was ex-
pected at the time of reperfusion, albeit a further increase
might occur until the end of the experiment.18,20
We additionally included 18 sham rats (seven treated
with CsA, 11 untreated) to determine the effects of the
same CsA injections on mitochondrial respiration and
calcium retention capacity (CRC), a marker of mPTP
opening. In the two groups, CRC was assessed in both
myocardium and gastrocnemius muscles, and mitochon-
drial respiration was determined in gastrocnemius muscle.
Blood CsA assay. Blood samples (500 mL) from addi-
tional CsA-treated sham rats were drawn from the internal
jugular vein on ethylenediaminetetraacetic acid tubes after
3 hours of general anesthesia when blood CsA near peaked
and analyzed using the MassTox reagent kit (Chromsys-
tems, Munich, Germany) as described in the Appendix
(online only).
Tissue processing. At the end of the experiment,
white superﬁcial gastrocnemius muscles were excised and
cleaned of adipose and connective tissue. One part was
kept on ice and immediately used for studying mitochon-
drial respiration in skinned ﬁbers. Delay between excision
and beginning of analysis remained <20 minutes, thus
avoiding secondary ischemia. The second part was immedi-
ately frozen in isopentane cooled by liquid nitrogen and
stored for subsequent analysis.
Study of muscle mitochondrial respiration in
skinned ﬁbers. Mitochondrial respiration was studied in
saponin-skinned ﬁbers, as previously described.9 Mea-
suring oxygen consumption ex vivo in skinned ﬁbers is
a unique way to determine the functional oxidative capacity
of skeletal muscle, allowing the study of the entire mito-
chondrial population within its cellular environment.
Brieﬂy, ﬁbers were separated, then permeabilized, in
a bath of solution containing 50 mg/mL saponin for 30
minutes at 4C, under shaking. The permeabilized ﬁbers
then were washed for 10 minutes under shaking in order toremove saponin. Fibers were placed in a bath with the respi-
ratory solution for 5 minutes twice in order to remove any
phosphates. Finally, oxygen consumption was measured
polarographically using aClark-type electrode in a 3-mLoxy-
graphic cell (Strathkelvin Instruments, Glasgow, Scotland).
Basal oxygen consumption (V0), and maximal ﬁber
respiration (Vmax) rates were measured at 22.1C under
continuous stirring in the presence of saturating amount
of adenosine diphosphate (ADP) as a phosphate acceptor.
Relative contributions of the respiratory chain complexes
I, III, and IV to the global mitochondrial respiratory rates
also were determined. When Vmax was recorded, electron
ﬂow went through complexes I, III, and IV. Complex I
was blocked with amobarbital (Amytal; 0.02 mM), and
complex II was stimulated with succinate (25 mM). Mito-
chondrial respiration then allowed determination of
complex II, III, and IV activities (Vsucc). N, N, N0, N0-tet-
ramethyl-p-phenylenediamine dihydrochloride (TMPD;
0.5 mM) and ascorbate (0.5 mM) were added as artiﬁcial
electron donors to cytochrome c. Under these conditions,
the activity of cytochrome c oxydase (complex IV) was
determined as an isolated step of the respiratory chain
(VTMPD/Asc). Mitochondrial coupling (coupling of phos-
phorylation to oxidation) was determined by calculating
the acceptor control ratio (ACR), the ratio between
ADP-stimulated respiration (Vmax) over basal respiration
(without ADP) with glutamate and malate as substrate
(V0). Fibers were then harvested and dried for 15 minutes
at 150C. Respiration rates are expressed as mmol O2/
min/g dry weight (DW).
Dihydroethidium staining. To detect the presence of
ROS in skeletal muscles, serial sections (10 mm thick) were
cut on a cryostat microtome and incubated with dihydro-
ethidium (DHE), which produces red ﬂuorescence when
oxidized to ethidium bromide by ROS including super-
oxide anion (see Appendix, online only).
Immunohistochemical procedure. To detect gastroc-
nemius inﬂammation, we used monocyte macrophage-2
(Millipore, Billerica, Mass) antibody on 10-mm-thick serial
sections of muscles (see Appendix, online only).9
Study of cyclophilin D expression in gastrocnemius
and myocardium. Cyclophilin D expression (relative to b-
actin) was measured by Western blot (Appendix, online
only)
Calcium retention capacity measurements in
gastrocnemius and myocardium. The resistance of mPTP
to opening after matrix Ca2þ challenge was determined in
permeabilized “ghost” muscle ﬁbers, characterized by
a lack of myosin, allowing Ca2þ uptake only by mitochon-
dria and prepared as described in the Appendix (online
only). The amount of Ca2þ necessary to trigger a massive
Ca2þ release was used as an indicator of the susceptibility of
mPTP to Ca2þ overload and expressed as mM/mg DW.
The Ca2þ concentration was calculated from a standard
curve relating [Ca2þ] to the ﬂuorescence of calcium green.
Statistical analysis. All data are expressed as mean 6
standard error of the mean and analyzed using the Prism
database (GraphPad Prism 5; Graph Pad Software, San
Fig 2. Effects of ischemia-reperfusion (IR) and cyclosporine A (IRþCsA) on mitochondrial coupling and respiratory
chain complexes activities. a, Acceptor control ratio (ACR). b, Maximal ﬁber mitochondrial respiration rates,
complexes I, III, and IV (Vmax). c, Combined activity of mitochondrial complexes II, III, and IV (Vsucc). d, Complex
IV activity (VTMPD/Asc). NS, Not signiﬁcant. *P < .05; **P < .01.
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groups, with post-test analysis between groups using the
Newman-Keuls test correcting for multiple comparisons.
P < .05 (two-tailed) was considered signiﬁcant. As previ-
ously observed, eight to 10 rats per group were required to
demonstrate a 30% reduction in mitochondrial function
after IR.7-9RESULTS
Effects of aortic cross-clamping and reperfusion on
skeletal muscle mitochondrial function, ROS produc-
tion, inﬂammation, and cyclophilin D content. As
expected, capillary lactate measurements revealed that
aortic cross-clamping signiﬁcantly increased anaerobicmetabolism in the IR group compared with the sham
group (16.6 6 1.0 mmol/L vs 2.7 6 0.4 mmol/L,
respectively; P < .0001).
IR decreased muscle mitochondrial coupling and
respiratory chain complexes activities. The ACR was
signiﬁcantly reduced (from 1.98 6 0.20 to 1.38 6
0.06; 30%; P ¼ .0092; Fig 2, a). The V0 tended to
decrease after IR from 3.16 6 0.34 to 2.96 6 0.28 mmol
O2/min/g DW in sham and IR, respectively. The Vmax
was signiﬁcantly decreased (from 5.98 6 0.56 mmol O2/
min/g DW to 4.08 6 0.38 mmol O2/min/g DW; 32%,
P ¼ .015; Fig 2, b) after 3 hours ischemia and 2 hours
reperfusion in gastrocnemius muscle. Vsucc and VTMPD/Asc
decreases were not statistically signiﬁcant after IR (Fig 2,
c and d).
Fig 3. Skeletal muscle production of reactive oxygen species in sham, after ischemia-reperfusion (IR), and after
cyclosporine A (IRþCsA). a, Dihydroethidium (DHE) ﬂuorescence intensity (arbitrary units [AU]). b, Examples of
DHE staining. NS, Not signiﬁcant. *P < .05; **P < .01.
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mation. Hind limb IR led to a signiﬁcant increase in DHE
ﬂuorescence in gastrocnemius sections (from 1812 6 322
arbitrary units [AU] to 3992 6 706 AU; þ120%; P ¼
.033), reﬂecting an increase in ROS, including superoxide
anion generation (Fig 3). Similarly, IR increased macro-
phage inﬁltration (Fig 4).
IR did not signiﬁcantly affect muscle cyclophilin D
expression. Cyclophilin D expression (relative to b-
actin) in gastrocnemius muscle was not signiﬁcantly
different in IR vs sham animals (1.29 6 0.14 vs 1.63 6
0.24; P ¼ .29).
Effects of CsA in sham rats and on IR-induced dele-
terious effects
Effects of CsA on normal gastrocnemius muscles.
In the additional CsA-treated sham rats, mitochondrial
respiratory chain complex activities were not signiﬁcantly
different from their respective values in untreated sham
animals (Table, online only).Cyclosporine A preserved mitochondrial respira-
tory chain coupling and partly protected complex I
activity against IR. Acknowledging that CsA absorption
might be modulated by surgical exposure and peritoneal
inﬂammation, in sham, blood CsA concentration was
2420 6 147 mg/L after 3 hours of general anesthesia.
This likely allowed potential biologic effects, as inferred
from previous data in the cardiac IR setting.20
Accordingly, CsA conditioning signiﬁcantly improved
the ACR (from 1.38 6 0.06 to 1.93 6 0.12; P ¼ .023 vs
IR) and restored its value close to the nonischemic control
(1.986 0.20; P¼ .95 vs sham; Fig 2, a). Indeed, V0 tended
to be reduced (2.69 6 0.25 mmol O2/min/g DW), and
Vmax (5.02 6 0.39 mmol O2/min/g DW) tended to be
increased compared with the IR group (4.08 6 0.38
mmolO2/min/g DW; P ¼ .33 vs IR; Fig 2, b).
Concerning Vsucc, IR alone induced a nonsigniﬁcant
decrease. Combining IR and CsA rendered the Vsucc
decrease signiﬁcant compared with control (Fig 2, c).
However, Vsucc was similar when comparing IR and
IRþCsA, thus supporting that the decreased activity in
Fig 4. Effects of ischemia-reperfusion (IR) and cyclosporine A
(IRþCsA) on inﬂammation. Immunohistochemical demonstra-
tion of the distribution of macrophages. Black arrows indicate the
presence of macrophages (original magniﬁcation, 400).
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 4 Pottecher et al 1105complexes II, III, and/or complex IV after IRþCsA was
mainly due to IR.
Similarly, CsA conditioning alone did not induce a signif-
icant change in VTMPD/Asc compared with IR (Fig 2, d).Taken together, because CsA did not increase
complex II, III, and IV activities, the beneﬁcial effects
observed for Vmax should be due mainly to an effect on
complex I.
Cyclosporine A reduced muscle ROS production
and inﬂammation. The CsA conditioning decreased
DHE ﬂuorescence in gastrocnemius sections (from
3992 6 706 AU to 1569 6 348 AU; P ¼ .0098; Fig 3),
indicating decreased generation of ROS and therefore
decreased oxidative stress in skeletal muscles submitted to
IR. Macrophage inﬁltration was also reduced by CsA
administration (Fig 4).
Mechanisms of CsA effects: implication of cyclophilin
D content and CRC
Cyclophilin D expression in heart and gastrocne-
mius muscles. Cyclophilin D expression relative to b-actin
was twice as large in myocardium compared with gastroc-
nemius in sham rats (5.52 6 0.86 AU vs 2.19 6 0.38
AU; P ¼ .009; Fig 5, a).
Functional implication of reduced cyclophilin D
content in gastrocnemius: CsA reduces CRC in heart
but not in gastrocnemius muscle. To investigate whether
the decreased level of cyclophilin D expression in gastroc-
nemius was functional, we tested the resistance of mPTP
to opening after matrix Ca2þ challenge in heart and
gastrocnemius with or without CsA. As expected, the
Ca2þ load required to open the mPTP was signiﬁcantly
increased by CsA treatment in myocardium (from
11.07 6 1.67 mM Ca2þ/mg DW to 37.65 6 11.41 mM
Ca2þ/mg DW; P ¼ .0098). Conversely, the Ca2þ load
required to open the gastrocnemius mPTP was not
different with and without CsA (from 10.85 6 1.35 mM
Ca2þ/mg DW to 12.11 6 2.77 mM Ca2þ/mg DW; P ¼
.65; Fig 5, b and c), supporting that CsA did not modify
gastrocnemius mPTP sensitivity to calcium load.
DISCUSSION
This study conﬁrms that IR impairs skeletal muscle
mitochondrial coupling and respiratory complex activities
and increases oxidative stress. Furthermore, after aortic
cross-clamping, CsA normalizes mitochondrial coupling,
ROS production, and macrophage inﬁltration. CsA also
partially restores mitochondrial respiratory chain complex
activities, likely in relation with gastrocnemius cyclophilin
D content.
Human skeletal muscle withstands 2.5 hours of warm
global ischemia before histologic injuries appear21 and
muscular ATP pool is exhausted.22 However, in surgical
clinical practice, although 3 hours of aortic clamping time
is longer than in most surgical procedures, aortic clamp
may be prolonged in robot-assisted laparoscopy and/or
by unpredictable complications such as arterial thrombosis
and vasospasm. Knowing that even subtle muscle impair-
ments may increase morbidity after abdominal aortic aneu-
rysm repair,2 muscle protection during vascular surgery
appears mandatory.
Fig 5. Cyclophilin D expression and Ca2þ concentration required to trigger mitochondrial permeability transition pore
(mPTP) opening in sham heart and gastrocnemius muscles. a, Cyclophilin D expression in myocardium and gastroc-
nemius muscles. b, Ca2þ concentration required to trigger mPTP opening in myocardium. c, Ca2þ concentration
required to trigger mPTP opening in gastrocnemius muscle. CsA, Cyclosporine A; NS, not signiﬁcant. **P < .01.
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chondrial coupling and mitochondrial oxidative capacity,
supporting that mitochondrial respiratory chain dysfunc-
tion is a sensitive marker of IR injury. Hind limb IR also
increased ROS production, as inferred from the enhanced
DHE staining in IR muscle. Similarly, IR increased muscle
inﬂammation. These data, in line with previous results,5,8
further support that mitochondrial dysfunction and
increased oxidative stress and inﬂammation are key factors
involved in IR mechanisms.
Several therapies, including controlled reperfusion23,24
and ischemic preconditioning7,25 and postconditioning,8,26
have been shown effective in protecting hind limbs
against IR-deleterious effects. Sometimes difﬁcult to apply,
such approaches might be associated with or perhaps
replaced by easier to perform pharmacologic approaches.
Thus, there is a general agreement that pharmacologicconditioning with CsA is effective in protecting the
myocardium from IR injury.11,20
In our study, CsA totally restored mitochondrial
coupling. Accordingly, rats fed with CsA 10 mg/kg/
d and 25 mg/kg/d for 3 weeks signiﬁcantly decreased
their gastrocnemius V0 (40% and 45%, respectively),
and CsA dose dependently increased the ACR in gastroc-
nemius muscles.27 Changes in V0 were less marked here,
perhaps because of the shorter duration of the experiments,
but our results are in line with these data.27
Reduced oxidative stress likely participated in CsA
beneﬁcial effects, as other protective approaches such as
ischemic postconditioning also decrease IR-induced
ROS production and muscle mitochondrial dysfunc-
tion.5,8 Accordingly, a constant cross-talk takes place
between the coupling of phosphorylation to oxidation
and mitochondrial ROS generation.28 Mitochondrial
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perpetuating a vicious circle that eventually leads to cell
death. As the mitochondrial respiratory chain is disrupted,
coupling decreases and more electrons leak; these are
involved in the generation of ROS leading to oxidative
stress and mPTP opening. In particular, mitochondrial
complexes I and III are the main sources of ROS produc-
tion during IR. However, when glutamate and malate are
used as mitochondrial substrates, the major site of ROS
production is complex I through reverse ﬂux of electrons
from complex II to complex I.29 If CsA preserves
complex I function, it prevents further ROS release
from this mitochondrial complex. Accordingly, CsA
clearly reduced ROS production. This is consistent with
a previous study demonstrating that CsA improved ATP
generation and decreased muscle myeloperoxidase activity
after 4 hours of ischemia and 2 hours of reperfusion.15
This fact, along with mitochondrial properties of skeletal
muscle being preserved in heart transplant recipients,
suggests that CsA was not harmful.30
Finally, there are interactions betweenCsAand inﬂamma-
tion in skeletal muscle. The CsA has been shown to decrease
muscular neutrophil inﬁltration during IR.15 Accordingly,
CsA reduced macrophage inﬁltration in our study.
Interestingly, however, despite its beneﬁcial effects on
mitochondrial coupling and ROS production, CsA only
partially protected skeletal muscle maximal oxidative
capacity. Several factors might limit CsA efﬁciency.
CsA vehicle can speciﬁcally decrease complex I activity
without altering mitochondrial coupling.31 Complex I
activity of the mitochondrial respiratory chain largely
participates in Vmax, and incomplete restoration of Vmax
might partly be explained by a potential deleterious effect
of CsA vehicle on complex I. Nevertheless, such data
were obtained in vitro using a concentration range much
higher than that used in our study. Compared with peak
CsA values observed 3 hours after administration in late
heart transplant recipients (808 6 295 ng/mL), our blood
CsA concentrations appeared higher.32 However, they
were well within the effective ranges previously demon-
strated to protect myocardium from IR injury.20 Further-
more, our additional experiment showed that similar CsA
doses did not affect gastrocnemius mitochondrial function.
Thus, an alternative explanation should be explored.
CsA cardioprotection is obtained through its binding
and inhibition of cyclophilin D, a mitochondrial protein
favoring mPTP opening and therefore apoptosis. It is
conceivable that CsA protection depends on cyclophilin D
content inmuscle cells.33,34 To further investigate themech-
anisms of CsA protective effects, we determined the expres-
sion of cyclophilin D in both skeletal and cardiac muscles and
measured their CRC, a marker of mPTP opening. Gastroc-
nemius cyclophilin D expression was decreased compared
with myocardium. This was associated with functional
changes. Indeed, CsA signiﬁcantly delayed myocardial
mPTP opening in response to Ca2þ load but failed to delay
gastrocnemius mPTP opening. Accordingly, the inhibitory
effect of CsA on mPTP opening was greater in case ofincreased cyclophilin D content in denervated muscle.33
Thus, CsA protection might depend on cyclophilin D
expression in muscle, possibly explaining CsA prevention
of infarction ﬂaps in pig latissimus dorsi muscle characterized
by a high level of cyclophilin D expression.26,35
Another potential mechanism explaining our results
may be inferred from the actions of CsA upon B- and T-
cell activation. The CsA upregulates immunoglobulin
production in preactivated B cells,36 but CsA inhibits
calcineurin-dependent nuclear factor of activated T cell
dephosphorylation and interrupts the transcription of
genes coding for interleukin-2, interleukin-4. and CD40
ligand. This decreases the efﬁcacy of T-cell–dependent
immune defenses37 and deserves further study.
CONCLUSIONS
The CsA normalized ROS production during aortic
cross-clamping and restored mitochondrial coupling.
Incomplete Vmax protectionmight be due to low cyclophilin
D expression in gastrocnemius, preventing CsA from block-
ing mPTP opening. Although controversial, combining
CsA and ischemic conditioning might be a promising alter-
native because they can have additive effects.38-40 This new
therapeutic approach might warrant being proposed to
patients undergoing prolonged vascular surgery procedures
in order to reduce skeletal muscle impairment and therefore
patient morbidity.
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Methods
Blood cyclosporine concentrations. The ONE-
MINUTE MassTox reagent kit (Chromsystems, Munich,
Germany) was used for the analysis of cyclosporine A
(CsA). Whole blood concentrations of cyclosporine were
qualiﬁed by high-performance liquid chromatography-
electrospray mass spectrometry with an Agilent 6410
apparatus (Agilent Technologies, Santa Carla, Calif). A
mixture of 50 mL of sample (control or calibrator), 25 mL of
reconstituted internal standard mix containing d12-cyclo-
sporine, and 100mL of extraction buffer was vortexed for 10
seconds and incubated for 2 minutes at room temperature.
Then 250 mL of precipitated reagent was added, vortexed,
and centrifuged for 5 minutes at 1500g.
Then, 30 mL of the supernatant was injected in the
liquid chromatography coupled to tandem mass spectrom-
etry. The mass transitions were monitored at a mass-to-
charge ratio of 1220 and 1203 for cyclosporine and 1232
and 1215 for d12-cyclosporine. The cycle time was 1.3
minutes injection to injection.
A standard curve was constructed by plotting the peak
area ratios against the theoretical whole blood concentra-
tions of cyclosporine. The lower limit of detection was 5
ng/mL. Concentrations were linear over the range from
25 to 2000 mg/L. The intra- and interday precision values
for the concentrations were all <10.0%, and the accuracy
ranged from 95% to 105% of the nominal value.
Dihydroethidium staining. To detect the presence of
reactive oxygen species, mainly superoxide anion, in skeletal
muscles, serial sections (10 mm thick) were cut on a cryostat
microtome and thaw mounted onto glass slides. After air
drying, slides were incubated for 30 minutes at 37C with
2.5 mM dihydroethidium in phosphate-buffered saline.
Dihydroethidium produces red ﬂuorescence when oxidized
to ethidium bromide by superoxide anion.1,2 After staining,
sections were rinsed, air dried, mounted in Vectashield
(Vector Laboratories, Burlingame, Calif), and coverslipped.
The sections were examined under an epiﬂuorescence
microscope (Nikon Eclipse E800; Nikon Instruments,
Amsterdam, The Netherlands) with a 20 epiﬂuorescence
objective, and emission signal was recorded with a Zeiss
573- to 637-nm ﬁlter. We analyzed micrographs using
Adobe Photoshop 6.0 (Adobe Systems, San Jose, Calif) in
order to determine ﬂuorescence intensity (arbitrary units)
in regions of interest. For each animal, 20 photographs
were taken in randomly determined regions of the same
muscle. A region of interest of red ﬂuorescence was deter-
mined, and the optimal sensitivity and speciﬁcity for con-
touring were deﬁned so as to build a script. This script was
applied to the 20 photographs, and the number of pixels in
each was recorded. We excluded values above the 90th and
under the 10th percentile and used the mean value.
Immunohistochemical procedure. To detect inﬂam-
mation in the gastrocnemius, we used monocyte
macrophage-2 antibody on serial sections (10-mm thick) ofmuscles.3 Brieﬂy, muscle sections were air dried and then
ﬁxed in paraformaldehyde 4% for 3 minutes. The sections
were placed in a 2% solution of hydrogen peroxide for 5
minutes, which served to reduce endogenous or pseudo-
peroxidase background staining. Primary antibody was used
at predetermined optimal dilutions. A standard indirect
immunoperoxidase procedure using biotinylated goat anti-
rat antibody (Millipore, Billerica, Mass) and streptavidin-
horseradish peroxidase (Millipore) was used to detect
binding of monocyte macrophage-2. The slides were devel-
oped by diaminobenzidine substrate. Tissues were counter-
stained brieﬂy with hematoxylin-eosin before mounting.
Study of cyclophilin D expression in myocardium
and gastrocnemius. At the end of reperfusion, hearts and
gastrocnemius muscles (n ¼ 5 per group) were rapidly
removed and frozen in liquid nitrogen. Total lysates were
prepared by homogenizing tissue lysis buffer (100 mL per
10 mg of tissue) containing 1% nonyl phenoxypolyethoxy-
lethanol, 20 mM Tris-HCl, 138 mMNaCl, 2.7 mM KCl, 1
mMMgCl2, 5% glycerol, 5 mM ethylenediaminetetraacetic
acid, 1 mM Na3VO4, 20 mM NaF, and 1 mM dithio-
threitol (pH 8), supplemented with a cocktail of protease
inhibitors. Protein content was evaluated using colorimetric
Bradford technique in a range from 0 to 1500 mg/mL of
bovine serum albumin (BSA). Thirty micrograms of heart
protein samples were separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis on gradient gels (15%
acrylamide) and transferred to nitrocellulose membranes.
Blots were blocked with 5% nonfat milk in Tris-buffered
saline. Membranes then were incubated in Tris-buffered
saline–Tween 20 (0.5%)–1% nonfat milk (4C overnight)
with mouse CyP D antibody (1/4000; Merck Chemicals,
Nottingham, UK) or rabbit actin antibody (1/1000; Sigma
Aldrich, Saint Quentin-Fallavier, France). Blots were
washed and incubated with horseradish peroxidase conju-
gated to appropriate anti-immunoglobulin G (1/25000;
Amersham GE Healthcare Europe GmbH, Saclay, France)
for 1 hour at room temperature. Enhanced chem-
iluminescence was performed with the ECL Western blot
detection kit (Amersham GE Healthcare Europe GmbH)
according to the manufacturer’s instructions, and blots
were exposed to hyperﬁlm. Equal loading was evaluated by
actin staining. Density of protein bands was computerized
(Image J software; National Institutes of Health, Bethesda,
Md).
Calcium retention capacity measurements in gastroc-
nemius andmyocardium. Fiber bundles were ﬁrst permea-
bilized with saponin and washed once in buffer S. Fibers
then were incubated for 30 minutes with agitation at 4C
in buffer R þ KCl (KCl 800 mM, CaK2 ethylene glycol tet-
raacetic acid (EGTA) 2.77 mM, K2EGTA 7.23 mM, MgCl2
1.38 mM, imidazole 20 mM, taurine 20 mM, dithiothreitol
0.5 mM, K-sulfonate of methane 90 mM, Na-sulfonate of
methane 10 mM, glutamate 5 mM, malate 2 mM, K2HPO4
3 mM; pH 7) to extract myosin and washed three times in
calcium retention capacity (CRC) þ BSA buffer for 10
minutes each (Tris-base 20 mM, saccharose 150 mM, KCl
Table (online only). Mitochondrial respiratory chain
complexes’ activities in sham rats treated or not treated
with cyclosporine A
Mitochondrial
respiration parameter
Group
Untreated sham
rats (n ¼ 11)
CsA-treated sham
rats (n ¼ 7) P value
Vmax 6.60 6 0.53 6.31 6 0.50 .72
Vsucc 4.40 6 0.41 4.05 6 0.26 .56
VTMPD/Asc 10.96 6 0.96 9.13 6 1.04 .24
CsA, Cyclosporine A; Vmax, maximal oxidative capacity; Vsucc, complex II,
III, and IV activities; VTMPD/Asc, complex IV activity.
Fig 6 (online only). Typical example of Ca2+-induced mitochondrial permeability transition pore (mPTP) opening
recording in mitochondria of ghost ﬁbers. AU, Arbitrary unit.
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BSA 2 mg/mL; pH 7.4).
Ca2D challenge. To determine sensitivity to mito-
chondrial permeability transition pore (mPTP) opening,
we submitted mitochondria within permeabilized ﬁbers
to progressive Ca2þ loading of the matrix under energized
conditions.4,5 Binding of exogenous Ca2þ to the contrac-
tile ﬁlaments, as well as Ca2þ uptake by the sarcoplasmic
reticulum, could interfere with measurement of mito-
chondrial Ca2þ uptake and release. To avoid these poten-
tial problems, we determined CRC in ghost ﬁbers. For
these CRC measurements, ghost ﬁbers (1.0-1.5 mg dry
ﬁber weight) were incubated at 24C in a quartz tank with
continuous magnetic stirring in 1 mL of CRC buffer (Tris-
base 20 mM, saccharose 150 mM, KCl 50 mM, KH2PO4 2
mM, succinate 5 mM, EGTA 9 mM; pH 7,4). Five
microliters of Ca2þ (1 mM) pulses were given every 5
minutes for skeletal muscle and every 2 minutes for heart
ﬁbers. Each pulse was recorded as a peak of extra-
mitochondrial Ca2þ concentration using the ﬂuorescent
probe calcium green (1 mM; excitation emission, 500-530
nm). Ca2þ is then very rapidly taken up by the mito-
chondria, resulting in a return of extramitochondrial Ca2þ
concentration to near baseline level. Following sufﬁcient
Ca2þ loading, extramitochondrial Ca2þ concentration
abruptly increases, indicating a massive release of Ca2þ by
mitochondria due to mPTP opening. A typical example of
Ca2þ-induced mPTP opening recording in mitochondria
of ghost ﬁbers is given in Fig 6 (online only).
RESULTS
Results are given in the Table (online only).REFERENCES
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